Holdings
Royalty Pharma Sub-Manager, LLC
As of Jun 30, 2026, Royalty Pharma Sub-Manager, LLC reported 4 positions worth US$242M. Largest: Cytokinetics, Incorporated, Zenas Biopharma, Inc. and Kailera Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Cytokinetics, Incorporated | 980K | US$83.5M | no change | Jun 30, 2026 |
| Zenas Biopharma, Inc. | 2.39M | US$60.6M | new | Jun 30, 2026 |
| Kailera Therapeutics, Inc. | 2.46M | US$54.1M | new | Jun 30, 2026 |
| Biohaven Ltd. | 2.94M | US$43.7M | no change | Jun 30, 2026 |